We are live on ! Find out more
NAP

New Amsterdam Partners Portfolio holdings

AUM $272M
1-Year Est. Return 12.21%
This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+12.21%
3 Year Est. Return
+73.94%
5 Year Est. Return
+120.95%
10 Year Est. Return
AUM
$470M
AUM Growth
+$48.1M
Cap. Flow
+$35M
Cap. Flow %
7.44%
Top 10 Hldgs %
24.35%
Holding
142
New
25
Increased
52
Reduced
39
Closed
26

Top Buys

Rank Stock Value
1
MANH icon
Manhattan Associates
MANH
+$10.6M
2
CUBI icon
Customers Bancorp
CUBI
+$7.74M
3
IOSP icon
Innospec
IOSP
+$7.47M
4
PBF icon
PBF Energy
PBF
+$6.85M
5
KNL
Knoll, Inc.
KNL
+$6.47M

Top Sells

Rank Stock Value
1
MSTR icon
Strategy Inc
MSTR
+$8.11M
2
DLX icon
Deluxe
DLX
+$7.34M
3
AVNT icon
Avient
AVNT
+$5.65M
4
INVX
Innovex International
INVX
+$5.34M
5
ZD icon
Ziff Davis
ZD
+$5.26M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.65%
2 Industrials 16.99%
3 Technology 16.31%
4 Financials 13.34%
5 Healthcare 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMT icon
101
American Tower
AMT
$82.1B
$510K 0.11%
3,855
+27
+0.7% +$3.46K
OKE icon
102
Oneok
OKE
$59.7B
$489K 0.1%
9,367
+58
+0.6% +$3K
ROST icon
103
Ross Stores
ROST
$73.3B
$483K 0.1%
8,375
+64
+0.8% +$3.99K
SNA icon
104
Snap-on
SNA
$20.3B
$457K 0.1%
+2,893
New +$473K
JLL icon
105
Jones Lang LaSalle
JLL
$17.4B
$432K 0.09%
3,452
+24
+0.7% +$2.76K
CHRW icon
106
C.H. Robinson
CHRW
$17.6B
$401K 0.09%
5,844
+40
+0.7% +$2.83K
BIIB icon
107
Biogen
BIIB
$32.3B
$399K 0.08%
1,471
+11
+0.8% +$2.91K
TSCO icon
108
Tractor Supply
TSCO
$18.1B
$374K 0.08%
34,465
+250
+0.7% +$2.98K
HAIN icon
109
Hain Celestial
HAIN
$66.1M
$333K 0.07%
8,581
+68
+0.8% +$2.46K
EW icon
110
Edwards Lifesciences
EW
$52B
$317K 0.07%
+8,049
New +$294K
DFS
111
DELISTED
Discover Financial Services
DFS
$314K 0.07%
5,043
+60
+1% +$3.72K
EQIX icon
112
Equinix
EQIX
$103B
$245K 0.05%
571
+15
+3% +$6.36K
SBNY
113
DELISTED
Signature Bank
SBNY
$245K 0.05%
+1,708
New +$242K
BFH icon
114
Bread Financial
BFH
$4.06B
$234K 0.05%
1,140
-1,600
-58% -$318K
CTXS
115
DELISTED
Citrix Systems Inc
CTXS
$231K 0.05%
+2,900
New +$240K
TRV icon
116
Travelers Companies
TRV
$77.2B
$225K 0.05%
1,779
-1,435
-45% -$177K
ALK icon
117
Alaska Air
ALK
$4.72B
-6,424
Closed -$592K
AMN icon
118
AMN Healthcare
AMN
$1.34B
-125,763
Closed -$5.11M
AVNT icon
119
Avient
AVNT
$4.1B
-165,632
Closed -$5.65M
AYI icon
120
Acuity Brands
AYI
$10B
-2,676
Closed -$546K
DLX icon
121
Deluxe
DLX
$1.08B
-101,769
Closed -$7.34M
HUBG icon
122
HUB Group
HUBG
$2.42B
-222,202
Closed -$5.16M
KHC icon
123
Kraft Heinz
KHC
$30.5B
-6,424
Closed -$583K
LDOS icon
124
Leidos
LDOS
$17.7B
-39,952
Closed -$2.04M
MSTR icon
125
Strategy Inc
MSTR
$50.6B
-431,740
Closed -$8.11M

Similar funds

New Amsterdam Partners's Q2 2017 Portfolio in Review

As of Q2 2017, New Amsterdam Partners held 142 positions worth $470M, up 11% from $422M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

New Amsterdam Partners deployed $35M of net new capital in Q2 2017, opening 25 new positions and adding to 52 existing holdings. Its largest new stake was Manhattan Associates: 224,089 shares worth $10.8M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 17% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Innovex International, an estimated $5.34M trimmed.

  • New Amsterdam Partners's largest Q2 2017 buy was Manhattan Associates: 224,089 shares worth $10.8M.
  • New Amsterdam Partners added most to Innospec in Q2 2017, an estimated $7.47M increase.
  • New Amsterdam Partners's biggest Q2 2017 reduction was Innovex International, cutting an estimated $5.34M.
  • New Amsterdam Partners fully exited Strategy Inc in Q2 2017, selling an estimated $8.11M.
  • New Amsterdam Partners's ten largest holdings make up 24% of its $470M portfolio in Q2 2017.
  • New Amsterdam Partners opened 25 new positions and closed 26 in Q2 2017.
  • New Amsterdam Partners's portfolio value rose 11% quarter-over-quarter to $470M.

Based on New Amsterdam Partners's 13F filing for Q2 2017, filed 2 Aug 2017.